The Effects of Lutein and Zeaxanthin Supplementation on Cognitive Function in Adults With Self-Reported Mild Cognitive Complaints: A Randomized, Double-Blind, Placebo-Controlled Study
Overview
Affiliations
Background: Lutein and zeaxanthin are fat-soluble, dietary carotenoids with high concentrations in human brain tissue. There have been a number studies confirming an association between lutein and zeaxanthin and cognitive function.
Purpose: Examine the effects of lutein and zeaxanthin supplementation on cognitive function in adults with self-reported cognitive complaints.
Study Design: Two-arm, parallel-group, 6-month, randomized, double-blind, placebo-controlled trial.
Methods: Ninety volunteers aged 40-75 years received either 10 mg of lutein and 2 mg of zeaxanthin, once daily or a placebo. Outcome measures included computer-based cognitive tasks, the Cognitive Failures Questionnaire, Behavior Rating Inventory of Executive Function, Profile of Mood States, and the Patient-Reported Outcomes Measurement Information System-29.
Results: Compared to the placebo, lutein and zeaxanthin supplementation was associated with greater improvements in visual episodic memory ( = 0.005) and visual learning ( = 0.001). However, there were no other statistically-significant differences in performance on the other assessed cognitive tests or self-report questionnaires. Lutein and zeaxanthin supplementation was well-tolerated with no reports of significant adverse effects.
Conclusion: The results from this trial suggest that 6-months of supplementation with lutein and zeaxanthin may improve visual memory and learning in community-dwelling adults with self-reported cognitive complaints. However, it had no other effect on other computer-based measures of cognitive performance or self-report measures of cognition, memory, mood, or physical function.
Effects and Mechanisms of Lutein on Aging and Age-Related Diseases.
Ye J, Cheng J, Xiong R, Chen H, Huang S, Li H Antioxidants (Basel). 2024; 13(9).
PMID: 39334773 PMC: 11428584. DOI: 10.3390/antiox13091114.
Goodhew S, Edwards M Psychon Bull Rev. 2024; .
PMID: 39249726 DOI: 10.3758/s13423-024-02573-6.
Kritz-Silverstein D, Bettencourt R Nutrients. 2024; 16(16).
PMID: 39203901 PMC: 11356842. DOI: 10.3390/nu16162765.
Pasenkiewicz-Gierula M, Hryc J, Markiewicz M Int J Mol Sci. 2024; 25(15).
PMID: 39125791 PMC: 11312187. DOI: 10.3390/ijms25158217.
Bas T Int J Mol Sci. 2024; 25(14).
PMID: 39062844 PMC: 11277215. DOI: 10.3390/ijms25147603.